Ignite Creation Date:
2024-05-06 @ 1:57 PM
Last Modification Date:
2024-10-26 @ 1:22 PM
Study NCT ID:
NCT04173585
Status:
COMPLETED
Last Update Posted:
2023-03-27
First Post:
2019-11-20
Brief Title:
TEAM-Trial Targeting Epigenetic Therapy Resistance in AML With Bortezomib
Sponsor:
University Hospital Heidelberg
Organization:
University Hospital Heidelberg
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-24
Completion Date Type:
ACTUAL
First Submit Date:
2019-11-20
First Submit QC Date:
November 20 2019
Study First Post Date:
2019-11-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-24
Last Update Post Date:
2023-03-27
Last Update Post Date Type:
ACTUAL